Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer

Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer

Purpose: Epidemiologic data from several populations suggest that metformin may decrease cancer risk and mortality in patients with colorectal cancer (CRC) and type II diabetes mellitus (DM). Although type II DM and CRC are major health problems in the Middle East, no investigations have been perfor...

Full description

Bibliographic Details
Main Authors: Amal Al Omari, Hadeel Abdelkhaleq, Maysa Al-Hussaini, Rim Turfa, Nour Awad, Manal M. Hassan, Mahmoud A. Alfaqih, Christopher R. Garrett
Format: Article
Language:English
Published: American Society of Clinical Oncology 2018-06-01
Series:Journal of Global Oncology
Online Access:http://ascopubs.org/doi/10.1200/JGO.18.00018

Internet

http://ascopubs.org/doi/10.1200/JGO.18.00018

Similar Items